Prev Arrow Stocks

Tilray Inc. ($TLRY) Stock Forecast: Down 5.3% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Tilray Inc.?

Tilray Inc. (TLRY) is a leading global cannabis company engaged in cultivation, processing, and distribution of medical cannabis products. The cannabis industry has been experiencing significant volatility due to regulatory changes and market demand fluctuations.

Why is Tilray Inc. going down?

TLRY stock is down 5.3% on May 30, 2025 19:11

  • TLRY experienced a bearish movement as investors might be concerned about increased competition in the cannabis industry.
  • The positive performance of other cannabis stocks could have shifted investor focus away from TLRY, leading to a sell-off.
  • Uncertainty surrounding regulatory environments or potential supply chain issues could have contributed to the downward pressure on TLRY's stock price.
  • Overall, the bearish movement in TLRY may be a reflection of broader market sentiment towards the cannabis sector rather than company-specific issues.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Cannabis Stock Gainers And Losers From May 29, 2025 - CLS Holdings USA ( OTC:CLSH ) , Cannabix Technologies ( OTC:BLOZF )

Rocky Mountain High RMHB shares closed up 36.00% at $0.00 CV Sciences CVSI shares closed up 16.87% at $0.03 MariMed MRMD shares closed up 13.70% at $0.09 Currenc Group CURR shares closed up 10.56% at $0.57 Greenlane Hldgs GNLN shares closed up 7.02% at $0.01

https://www.benzinga.com/insights/cannabis/25/05/45681887/cannabis-stock-gainers-and-losers-from-may-29-2025

0 News Article Image Cannabis Stock Gainers And Losers From May 29, 2025 - CLS Holdings USA  ( OTC:CLSH ) , Cannabix Technologies  ( OTC:BLOZF )

Tilray Inc. Price History

17.03.2025 - TLRY Stock was down 13.9%

  • The bearish movement in Tilray's stock today could be attributed to the broader market reaction to China's new tariffs, which have reignited previous market patterns that led to significant gains for investors.
  • Despite the positive developments in Tilray's expansion and success in the craft brewing industry, external factors such as geopolitical tensions may have overshadowed the market sentiment.
  • Investors may be concerned about the potential impact of these tariffs on Tilray's international operations and supply chain, leading to a sell-off of the stock.
  • The unveiling of a new craft beer product, Camp Coldie, in partnership with Scout Campers by 10 Barrel Brewing, a Tilray brand, while positive, may not have been sufficient to counterbalance the negative market sentiment influenced by external factors.

13.04.2025 - TLRY Stock was up 6.8%

  • The reintroduction of Delayed Pilsner by Blue Point targeting NYC commuters may have contributed to Tilray's bullish movement, presenting potential for increased sales and market reach.
  • The launch of Cognac Cask Finish Whiskey by Tilray's Breckenridge brand might have added to investor optimism and interest in the company's diversification efforts.
  • An upcoming live session with Matt Maley to discuss the Fed's next move could have generated anticipation and positive sentiment among investors, potentially boosting buying activity and lifting the stock price.

24.03.2025 - TLRY Stock was up 5.5%

  • Tilray introduced a new product, Breckenridge Cognac Cask Whiskey, priced at $59.99, demonstrating the company's efforts to diversify and enter new markets.
  • The consideration of a reverse stock split to comply with Nasdaq regulations highlights Tilray's focus on regulatory compliance and long-term viability.
  • The stock's bullish movement may also be linked to speculations about new tariffs in China, which could create advantageous trading conditions for the company.

30.04.2025 - TLRY Stock was down 5.3%

  • TLRY experienced a bearish movement as investors might be concerned about increased competition in the cannabis industry.
  • The positive performance of other cannabis stocks could have shifted investor focus away from TLRY, leading to a sell-off.
  • Uncertainty surrounding regulatory environments or potential supply chain issues could have contributed to the downward pressure on TLRY's stock price.
  • Overall, the bearish movement in TLRY may be a reflection of broader market sentiment towards the cannabis sector rather than company-specific issues.

16.03.2025 - TLRY Stock was up 9.1%

  • The bullish movement in Tilray's stock today could be attributed to the positive news of its U.S. Beverage division achieving a significant milestone by ranking #4 among the top craft brewing companies in the U.S.
  • This accomplishment showcases Tilray's strong position and growth potential in the competitive craft brewing industry, which likely boosted investor confidence and drove the stock price higher.
  • The unveiling of Camp Coldie, a new IPA brewed in partnership with Scout Campers by 10 Barrel Brewing Co., a Tilray brand, also adds to the positive sentiment surrounding Tilray's presence and innovation in the craft beer market, further contributing to the bullish movement in the stock.

28.03.2025 - TLRY Stock was down 5.1%

  • Tilray unveiled Breckenridge Cognac Cask Whiskey, a move that might have diverted investor focus away from its core cannabis business, potentially leading to a negative market sentiment.
  • The proposal for a reverse stock split to maintain Nasdaq compliance could have raised concerns among investors about the company's financial health and future prospects.
  • The re-ignition of China's new tariffs and their impact on market patterns may have added to the bearish pressure on Tilray's stock, as investors reacted to the broader market uncertainties.

14.04.2025 - TLRY Stock was down 5.3%

  • The introduction of new cannabis drinks and gummies by XMG Atomic Sours, a part of Tilray's unit High Park, could have led to increased competition within the cannabis edibles space, potentially impacting Tilray's market share and investor sentiment negatively.
  • The market might be reacting to the news of potential oversaturation in the cannabis edibles market, leading to concerns about Tilray's future sales and profitability.
  • Investors may be cautious about the long-term growth prospects of Tilray, considering the evolving landscape of the cannabis industry and the need for continuous innovation to stay competitive.

23.04.2025 - TLRY Stock was down 96.3%

  • Tilray expanding its medical cannabis reach in Germany with the launch of Good Supply could have raised concerns among investors about increased competition in the market.
  • The market might be reacting to uncertainties surrounding the regulatory environment for cannabis products in Germany, impacting Tilray's growth prospects.
  • The bearish movement could also be influenced by broader market trends or profit-taking activities by investors following a recent price surge in the stock.

08.03.2025 - TLRY Stock was down 8.7%

  • TLRY's Q3 financial results showed a loss and revenue figures below expectations, likely influencing the negative stock movement as investors reacted unfavorably to the performance.
  • Concerns arose due to Tilray shifting cultivation of its flagship cannabis strain, Good Supply Jean Guy, to a high-tech facility in Québec, which may have led to worries about potential disruptions or costs in the transition, impacting the stock price.
  • While the company remains dedicated to Quebec and plans to launch new packaging for Jean Guy, uncertainties in the market regarding the overall impact on Tilray's financials have contributed to the bearish trend.
  • The introduction of Atwater Light by Atwater Brewery, although unrelated to Tilray, could have drawn investor focus away from TLRY, potentially affecting its stock performance negatively.

22.03.2025 - TLRY Stock was up 5.6%

  • Although Tilray's shares traded lower by 6.2% during the session, the overall market exhibited a bullish trend, suggesting a robust recovery.
  • The introduction of Tilray's cannabis-infused medical edibles in Australia through the Good Supply brand likely attracted investor attention and contributed to the positive market sentiment.
  • Achieving the #4 rank on the Brewers Association list of top producing craft brewers in the U.S. may have enhanced Tilray's reputation and investor confidence, further driving the bullish movement.
  • The potential impact of China's new tariffs on market dynamics was potentially overshadowed by Tilray's favorable developments, influencing the bullish momentum.

22.04.2025 - TLRY Stock was down 5.7%

  • The announcement of Tilray Medical bringing Canada's iconic cannabis brand Good Supply to Germany did not seem to have a positive impact on TLRY's stock price.
  • Investors might have been expecting a different market reaction to the expansion into the German market, leading to disappointment and selling pressure on the stock.
  • The bearish movement could be a result of profit-taking by traders who were anticipating a more significant price increase following the news about Tilray's expansion efforts.

30.03.2025 - TLRY Stock was down 5.8%

  • The introduction of a non-alcoholic version of the Apocalypse IPA by 10 Barrel Brewing, a subsidiary of Tilray, may have raised investor concerns about the company's diversification efforts.
  • Widmer Brothers Brewing's 40th-anniversary celebrations potentially diverted consumer attention from Tilray's products, impacting TLRY stock performance negatively.
  • The launch of Breckenridge Cognac Cask Whiskey and the consideration of a reverse stock split by Tilray may not have excited investors, leading to a downward movement in the stock price.
  • Growing market uncertainties, including China's imposition of new tariffs, likely added to the bearish sentiment surrounding Tilray Brands' stock.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.
OSZAR »